HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$26.59
Day range
$26.05 - $27.67
Year range
$5.83 - $29.73
Market cap
1.25B USD
Avg Volume
334.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.14M | 105.87% |
Net income | -52.22M | -37.51% |
Net profit margin | — | — |
Earnings per share | -1.25 | — |
EBITDA | -55.15M | -39.03% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 273.28M | 48.58% |
Total assets | 293.08M | 46.58% |
Total liabilities | 53.46M | 36.65% |
Total equity | 239.63M | — |
Shares outstanding | 42.11M | — |
Price to book | 4.67 | — |
Return on assets | -44.00% | — |
Return on capital | -52.42% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -52.22M | -37.51% |
Cash from operations | -41.74M | -34.83% |
Cash from investing | -112.29M | -320,731.43% |
Cash from financing | 1.72M | -99.03% |
Net change in cash | -152.55M | -203.93% |
Free cash flow | -24.09M | -45.12% |
About
Founded
2019
Headquarters
Website
Employees
130
